Results 101 to 110 of about 12,044 (250)
Facial expression recognition for emotion perception: A comprehensive science mapping
Ibrain, Volume 12, Issue 1, Page 38-51, Spring 2026.Facial expression recognition (FER) has emerged as a pivotal interdisciplinary research domain, bridging computer science, psychology, neuroscience, and medicine. By mapping the FER scientific knowledge graph, the study aimed to explore the technological evolution and forecast future application trends in this field.
Hou‐Ming Kan +10 more
wiley +1 more source
Familial Autoimmune Myasthenia Gravis (Report Of 3 Cases)
Annals of Indian Academy of Neurology, 2003 Familial Autoimmune myasthenia gravis is rare, occurring in only about 1.3% cases of myasthenia gravis (MG). Here in we report a family with three family members affected by MG. Proband presented with generalised myasthenia where as the other two
Girija A. S, Madhukar M, John John K
doaj
Neurological complications of immune checkpoint inhibitors: what happens when you \u27take the brakes off\u27 the immune system. [PDF]
, 2018 Patients with advanced malignancies treated with immune checkpoint inhibitors are at increased risk for developing immune-related neurological complications.
Dalakas, Marinos
core +1 more source
Digestive Endoscopy, Volume 38, Issue 3, March 2026.ABSTRACT Objectives Sedation during colonoscopy is becoming increasingly important. Remimazolam, an ultra‐short‐acting benzodiazepine, has a shorter pharmacokinetic half‐life than that of midazolam. This study examined whether remimazolam provides superior sedation during colonoscopy in Japanese patients.
Daisuke Yamaguchi +18 more
wiley +1 more source
BMC Neurology, 2017 Background Seronegative ocular myasthenia gravis (OMG) is diagnosed by ocular symptoms with supporting SFEMG, typically of frontalis or extensor digitorum muscles.
Goran Rakocevic +2 more
doaj +1 more source
Anestesia peridural torácica para cirugía plástica de mama en paciente portadora de miastenia gravis: relato de caso [PDF]
, 2005 BACKGROUND AND OBJECTIVES: Myasthenia gravis is a chronic autoimmune disease characterized by skeletal muscles weakness promoted by decreased acetylcholine receptors in the neuromuscular junction.
Barbosa, Fabiano Timbó +3 more
core +5 more sources
European Journal of Neurology, Volume 33, Issue 3, March 2026.Conceptual framework supporting Minimal Symptom Expression (MSE) as a patient‐centric treatment goal in generalized myasthenia gravis. Guidelines prioritize minimal manifestations (MM) or better (MGFA‐PIS); MM is clinician‐judgment based and not instrument‐defined. MSE (MG‐ADL 0‐1) is standardized, actionable, and widely used. Across Phase III programs
Andreas Meisel +5 more
wiley +1 more source
Miasthenia gravis in pediatric age
Acta Médica del Centro, 2008 Background: Myasthenia gravis is an autoimmune disorder characterized by fluctuating muscle weakness and fatigue of different muscle groups, secondary to a synaptic transmission alteration caused by the blockade and destruction of the acetylcholine ...
Liubka María Pérez Mederos +3 more
doaj
European Journal of Neurology, Volume 33, Issue 3, March 2026.This prospective cohort study identifies independent predictors of relapse following complete treatment discontinuation in 196 myasthenia gravis (MG) patients who achieved minimal symptom expression (MSE). Cox regression analysis revealed late‐onset MG (age ≥ 50 years) as a risk factor, while rituximab therapy, longer treatment duration, and extended ...
Dingxian He +7 more
wiley +1 more source
The evaluation of approaches to the treatment of myasthenia gravis.
Medičnì Perspektivi, 2019 Myasthenia gravis is a relatively rare autoimmune disease with an undetermined aetiology which affects neuromuscular junctions. Currently, the following approaches to the treatment of myasthenia gravis are mainly distinguished: symptomatic treatment with
O. I. Kalbus +4 more
doaj +1 more source